| Innovator Capital was established in 2003 and focuses on the provision of expert strategic and capital markets advice, transaction arranging and M&A services for a broad range of emerging Bio - Medical and Environmental technology companies regardless of their nationality, whether they are private, publicly quoted or just starting out.
We address the continuing unsatisfied capital requirement and other needs of such companies by assisting them in their understanding of the numerous alternatives and opportunities available around the world. Innovator Capital's objective is to provide companies and their shareholders with a well crafted, innovative and high value-added approach to capital raising, partnering, product licensing and other key decision making.
Innovator develops tailor-made solutions to satisfy companies' individual requirements particularly in situations where a company's valuation is perceived to be below reasonable levels. These solutions are executed bearing in mind the limited amount of time that managements have to devote to non-operational issues, they are then freed to concentrate on the execution of their business plans rather than spending an inordinate amount of time looking for capital or lifting the awareness of their organisations.
Innovator Capital has various new approaches to funding for public and private companies, which have been proven in numerous world financial centres. The approaches allow companies to determine the precise timing and scale of their access to the capital markets, while delivering greater direct control over pricing. Innovator benefits from: the track record and multinational expertise of its founder; the breadth and depth of knowledge across the organisation; the edge it has as a result of different and objective use of the equity capital markets; and the nature of the business model we follow in multiple financial markets. It is at the forefront of innovation.
Contact Us >> |
